News World Center

Amyotrophic Lateral Sclerosis (ALS) Treatment Market Worth Around 380 Million USD by 2025 | Vigorous CAGR 6.9% In Global Market

Press release   •   Apr 11, 2019 09:21 EDT

According to Ameco Research, the Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is projected to grow at vigorous CAGR of around 6.9% over the forecast period and market size will reach worth around 380 Million US$ in 2018-2025.

The Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is an in depth study analyzing the current state and forecast 2018-2025. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market discusses the opportunity areas for investors.

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Download Sample Copy Of This Report From Here: http://www.amecoresearch.com/sample/11759

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig's disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig's disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die. According to Centers for Disease Control and Prevention (CDC), 14,000 - 15,000 Americans had ALS in 2016.

The classification of Amyotrophic Lateral Sclerosis (ALS) Treatment includes Riluzole, Edaravone (Radicava) and Other and the proportion of Edaravone (Radicava) in 2017 is about 67.7%, Radicava is approved in Japan and Korea in 2015, and through the FDA in 2017.

In 2018, the global Amyotrophic Lateral Sclerosis (ALS) Treatment market size was 240 million US$ and it is expected to reach 380 million US$ by the end of 2025, with a vigorous CAGR of 6.9% during 2019-2025.

View Detail Report With Complete Table of Content@ http://www.amecoresearch.com/market-report/global-amyotrophic-lateral-sclerosis-als-treatment-market-arr-11759

This report focuses on the global Amyotrophic Lateral Sclerosis (ALS) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Amyotrophic Lateral Sclerosis (ALS) Treatment development in United States, Europe and China.

The key players covered in this study
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma

Market segment by Type, the product can be split into
Riluzole
Edaravone (Radicava)
Other

Market segment by Application, split into
Hospital
Drugs Store
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

Available customization:

With the given market information, Ameco research offers customization's in line with the company's specific wishes. The following customization choices unit of measurement accessible for the report:
Regional and country-level analysis of the Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market - Industry Size, Share, Trends and Forecast 2018 - 2025

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Riluzole
1.4.3 Edaravone (Radicava)
1.4.4 Other
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Drugs Store
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size
2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Regions (2014-2025)
2.2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Manufacturers
3.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Area Served
3.3 Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product/Solution/Service
3.4 Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2014-2019)
4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2014-2019)
5.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in United States
5.3 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
5.4 United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application

6 Europe
6.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2014-2019)
6.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Europe
6.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
6.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application

7 China
7.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2014-2019)
7.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in China
7.3 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
7.4 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application

8 Japan
8.1 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2014-2019)
8.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Japan
8.3 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
8.4 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2014-2019)
9.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
9.4 Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application

10 India
10.1 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2014-2019)
10.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in India
10.3 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
10.4 India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2014-2019)
11.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players in Central & South America
11.3 Central & South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
11.4 Central & South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application

12 International Players Profiles
12.1 Mitsubishi Tanabe Pharma
12.1.1 Mitsubishi Tanabe Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
12.1.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2014-2019)
12.1.5 Mitsubishi Tanabe Pharma Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
12.2.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2014-2019)
12.2.5 Sanofi Recent Development
12.3 Mylan Pharma
12.3.1 Mylan Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
12.3.4 Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2014-2019)
12.3.5 Mylan Pharma Recent Development
12.4 Apotex
12.4.1 Apotex Company Details
12.4.2 Company Description and Business Overview
12.4.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
12.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2014-2019)
12.4.5 Apotex Recent Development
12.5 Glemark Generics
12.5.1 Glemark Generics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
12.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2014-2019)
12.5.5 Glemark Generics Recent Development
12.6 Covis Pharma
12.6.1 Covis Pharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
12.6.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2014-2019)
12.6.5 Covis Pharma Recent Development
12.7 Sun Pharma
12.7.1 Sun Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
12.7.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2014-2019)
12.7.5 Sun Pharma Recent Development
12.8 Lunan Pharma
12.8.1 Lunan Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
12.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2014-2019)
12.8.5 Lunan Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/11759

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:
Email: sales@amecoresearch.com | + 1 407 915 4157

Browse More For Latest Update :

Ameco Research